American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The Current State of Systemic Therapy of Metastatic Uveal Melanoma150
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative138
Prognostic Biomarkers in Evolving Melanoma Immunotherapy133
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions124
Economic Burden of Chronic Hand Eczema: A Review94
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments90
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review89
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments85
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study81
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know73
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review68
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?67
Pathophysiology of Generalized Pustular Psoriasis66
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data61
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology58
Behçet Disease: An Update for Dermatologists52
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution52
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris49
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants49
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi47
Viral Venereal Diseases of the Skin47
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”46
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials45
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion44
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature43
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment43
Skin Cancer in People of Color: A Systematic Review42
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study42
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation42
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients42
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management39
A Practice Approach to Acne Fulminans in Adolescents39
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives38
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis38
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis36
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment36
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist36
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review35
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates34
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa34
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching34
Patient and Public Involvement in Dermatology Research: A Review33
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases33
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm32
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options30
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis30
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons30
Oral Lichen Planus: An Update on Diagnosis and Management30
Individualized Neoantigen-Directed Melanoma Therapy29
Frontal Fibrosing Alopecia: An Update29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists29
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”29
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study28
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada28
Targeting Inflammation in Acne: Current Treatments and Future Prospects27
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential27
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History27
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients26
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)26
Management of Acne in Pregnancy25
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program25
Approach to the Atypical Wound23
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”22
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management22
Identifying and Treating Ocular Manifestations in Psoriasis21
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study21
Acknowledgement to Referees21
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea21
Investigational Treatments for Epidermolysis Bullosa20
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians20
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis20
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year20
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study20
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey20
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-219
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color19
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)19
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study19
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials19
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 19
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts19
Review of Perineural Invasion in Keratinocyte Carcinomas19
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study18
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights18
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study18
0.10890507698059